Austin Mark John 4
4 · Perspective Therapeutics, Inc. · Filed Jun 14, 2023
Insider Transaction Report
Form 4
Austin Mark John
Controller/Prin Fin&Acct Offic
Transactions
- Award
Stock Options (right to buy)
2023-06-12+225,000→ 773,115 totalExercise: $0.55Exp: 2033-06-12→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]25% vested as of 6/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 6/12/2024, until fully vested.